Want to join the conversation?
$NOV 2Q15 Call: NOV earned $0.74 per fully diluted share in its 2Q15, excluding $17MM in pre-tax charges were $0.03 per share after related to severance from facilities closures. Earnings were $0.77 per fully diluted share, down 32% sequentially from 1Q15 and down 48% from 2Q14, excluding other items from all periods.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?